US Stock MarketDetailed Quotes

XOMAP XOMA CORP 8.625% CUM PERP PFD SER A

Watchlist
  • 25.770
  • +0.190+0.74%
Close Mar 21 16:00 ET
0Market Cap0.00P/E (TTM)

XOMA CORP 8.625% CUM PERP PFD SER A Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
24.29%-13.75M
26.08%-2.9M
-310.91%-8.63M
137.83%2.73M
-0.47%-4.95M
-40.99%-18.16M
-0.95%-3.93M
42.70%-2.1M
-66.97%-7.21M
-388.01%-4.92M
Net income from continuing operations
66.15%-13.82M
80.27%-3.97M
-213.00%-17.24M
396.02%15.99M
12.41%-8.6M
-138.72%-40.83M
-236.50%-20.11M
-31.86%-5.51M
-15.63%-5.4M
-330.39%-9.81M
Operating gains losses
-15,708.13%-19.2M
--0
---19.32M
--0
-4.07%118K
44.71%123K
--0
--0
--0
44.71%123K
Depreciation and amortization
-76.00%216K
-7.56%208K
-98.66%3K
-98.67%3K
-99.12%2K
765.38%900K
131.96%225K
5,500.00%224K
22,400.00%225K
11,200.00%226K
Deferred tax
---5.66M
----
----
----
----
--0
----
----
----
----
Other non cash items
943.44%17.25M
1,523.81%26.19M
79,883.33%14.4M
-94,544.00%-23.66M
580.85%320K
872.35%1.65M
3,651.16%1.61M
-58.14%18K
-159.52%-25K
11.90%47K
Change In working capital
20.97%-2.79M
166.12%685K
-990.14%-3.07M
82.45%-1.01M
-79.17%604K
-1,849.72%-3.53M
-222.03%-1.04M
182.93%345K
-941.20%-5.74M
4,701.59%2.9M
-Change in receivables
16.75%-835K
17.38%-794K
-160.49%-519K
41.56%-523K
20,120.00%1M
-582.21%-1M
-6,506.67%-961K
7,900.00%858K
-4,575.00%-895K
-102.72%-5K
-Change in prepaid assets
37.90%302K
-11.16%374K
605.71%531K
-122.95%-816K
-20.82%213K
408.45%219K
54.78%421K
-290.91%-105K
39.20%-366K
31.86%269K
-Change in payables and accrued expense
405.54%1.6M
9,403.23%2.95M
-1,155.35%-2.27M
126.37%1.03M
-103.36%-105K
-129.82%-523K
-97.52%31K
1,435.71%215K
-824.58%-3.89M
6,886.96%3.12M
-Change in other current liabilities
-149.12%-284K
-1,750.00%-99K
-472.22%-103K
-28.85%-67K
70.00%-15K
41.54%-114K
111.76%6K
62.50%-18K
-8.33%-52K
-4.17%-50K
-Change in other working capital
-69.35%-3.57M
-226.83%-1.74M
-17.52%-711K
-17.64%-627K
-12.13%-490K
-12.31%-2.11M
16.19%-533K
-42.02%-605K
-16.38%-533K
-22.41%-437K
Cash from discontinued investing activities
Operating cash flow
24.29%-13.75M
26.08%-2.9M
-310.91%-8.63M
137.83%2.73M
-0.47%-4.95M
-40.99%-18.16M
-0.95%-3.93M
42.70%-2.1M
-66.97%-7.21M
-388.01%-4.92M
Investing cash flow
Cash flow from continuing investing activities
-3,874.54%-28.26M
-761.06%-36.43M
73.32%9.52M
231.55%5.9M
-0.17%-7.25M
96.48%-711K
136.14%5.51M
21,030.77%5.49M
-4.48M
-44.68%-7.23M
Net PPE purchase and sale
-17.65%-20K
82.35%-3K
--0
--0
---17K
---17K
---17K
--0
--0
--0
Net business purchase and sale
---1.25M
---20.18M
72.92%20.26M
----
----
--0
--0
--11.72M
----
----
Net investment purchase and sale
---3.24M
----
----
----
----
--0
----
----
----
----
Net other investing changes
-3,322.48%-23.75M
-335.44%-13.02M
----
----
0.07%-7.23M
86.05%-694K
--5.53M
----
----
---7.23M
Cash from discontinued investing activities
Investing cash flow
-3,874.54%-28.26M
-761.06%-36.43M
73.32%9.52M
231.55%5.9M
-0.17%-7.25M
96.48%-711K
136.14%5.51M
21,030.77%5.49M
---4.48M
-44.68%-7.23M
Financing cash flow
Cash flow from continuing financing activities
-109.23%-11.13M
-100.86%-1.07M
-192.47%-4M
5.24%-1.1M
-262.28%-4.96M
2,809.35%120.59M
9,517.10%124.49M
-8.57%-1.37M
-2.73%-1.17M
-86.12%-1.37M
Net issuance payments of debt
-105.31%-6.9M
--0
---3.29M
--0
---3.62M
--130M
--130M
--0
--0
--0
Net common stock issuance
---13K
--0
--0
--0
---13K
--0
--0
--0
--0
--0
Cash dividends paid
0.00%-5.47M
0.00%-1.37M
0.00%-1.37M
0.00%-1.37M
0.00%-1.37M
0.00%-5.47M
0.00%-1.37M
0.00%-1.37M
0.00%-1.37M
0.00%-1.37M
Proceeds from stock option exercised by employees
1,018.88%5.21M
321.32%1.09M
--1.77M
90.87%397K
--1.96M
-80.74%466K
460.87%258K
--0
-30.43%208K
--0
Net other financing activities
10.16%-3.95M
82.14%-785K
---1.12M
---133K
---1.92M
-214.81%-4.4M
---4.4M
--0
----
----
Cash from discontinued financing activities
Financing cash flow
-109.23%-11.13M
-100.86%-1.07M
-192.47%-4M
5.24%-1.1M
-262.28%-4.96M
2,809.35%120.59M
9,517.10%124.49M
-8.57%-1.37M
-2.73%-1.17M
-86.12%-1.37M
Net cash flow
Beginning cash position
175.91%159.55M
338.62%146.82M
376.77%149.92M
221.45%142.4M
175.91%159.55M
-39.37%57.83M
-57.24%33.47M
-62.20%31.45M
-50.02%44.3M
-39.37%57.83M
Current changes in cash
-152.23%-53.13M
-132.04%-40.4M
-253.13%-3.1M
158.49%7.52M
-26.79%-17.15M
370.90%101.72M
716.25%126.08M
141.39%2.03M
-135.83%-12.86M
-100.56%-13.53M
End cash Position
-33.30%106.42M
-33.30%106.42M
338.62%146.82M
376.77%149.92M
221.45%142.4M
175.91%159.55M
175.91%159.55M
-57.24%33.47M
-62.20%31.45M
-50.02%44.3M
Free cash flow
24.25%-13.77M
26.32%-2.91M
-310.91%-8.63M
137.83%2.73M
-0.81%-4.96M
35.38%-18.18M
79.39%-3.94M
42.70%-2.1M
-66.97%-7.21M
-388.01%-4.92M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 24.29%-13.75M26.08%-2.9M-310.91%-8.63M137.83%2.73M-0.47%-4.95M-40.99%-18.16M-0.95%-3.93M42.70%-2.1M-66.97%-7.21M-388.01%-4.92M
Net income from continuing operations 66.15%-13.82M80.27%-3.97M-213.00%-17.24M396.02%15.99M12.41%-8.6M-138.72%-40.83M-236.50%-20.11M-31.86%-5.51M-15.63%-5.4M-330.39%-9.81M
Operating gains losses -15,708.13%-19.2M--0---19.32M--0-4.07%118K44.71%123K--0--0--044.71%123K
Depreciation and amortization -76.00%216K-7.56%208K-98.66%3K-98.67%3K-99.12%2K765.38%900K131.96%225K5,500.00%224K22,400.00%225K11,200.00%226K
Deferred tax ---5.66M------------------0----------------
Other non cash items 943.44%17.25M1,523.81%26.19M79,883.33%14.4M-94,544.00%-23.66M580.85%320K872.35%1.65M3,651.16%1.61M-58.14%18K-159.52%-25K11.90%47K
Change In working capital 20.97%-2.79M166.12%685K-990.14%-3.07M82.45%-1.01M-79.17%604K-1,849.72%-3.53M-222.03%-1.04M182.93%345K-941.20%-5.74M4,701.59%2.9M
-Change in receivables 16.75%-835K17.38%-794K-160.49%-519K41.56%-523K20,120.00%1M-582.21%-1M-6,506.67%-961K7,900.00%858K-4,575.00%-895K-102.72%-5K
-Change in prepaid assets 37.90%302K-11.16%374K605.71%531K-122.95%-816K-20.82%213K408.45%219K54.78%421K-290.91%-105K39.20%-366K31.86%269K
-Change in payables and accrued expense 405.54%1.6M9,403.23%2.95M-1,155.35%-2.27M126.37%1.03M-103.36%-105K-129.82%-523K-97.52%31K1,435.71%215K-824.58%-3.89M6,886.96%3.12M
-Change in other current liabilities -149.12%-284K-1,750.00%-99K-472.22%-103K-28.85%-67K70.00%-15K41.54%-114K111.76%6K62.50%-18K-8.33%-52K-4.17%-50K
-Change in other working capital -69.35%-3.57M-226.83%-1.74M-17.52%-711K-17.64%-627K-12.13%-490K-12.31%-2.11M16.19%-533K-42.02%-605K-16.38%-533K-22.41%-437K
Cash from discontinued investing activities
Operating cash flow 24.29%-13.75M26.08%-2.9M-310.91%-8.63M137.83%2.73M-0.47%-4.95M-40.99%-18.16M-0.95%-3.93M42.70%-2.1M-66.97%-7.21M-388.01%-4.92M
Investing cash flow
Cash flow from continuing investing activities -3,874.54%-28.26M-761.06%-36.43M73.32%9.52M231.55%5.9M-0.17%-7.25M96.48%-711K136.14%5.51M21,030.77%5.49M-4.48M-44.68%-7.23M
Net PPE purchase and sale -17.65%-20K82.35%-3K--0--0---17K---17K---17K--0--0--0
Net business purchase and sale ---1.25M---20.18M72.92%20.26M----------0--0--11.72M--------
Net investment purchase and sale ---3.24M------------------0----------------
Net other investing changes -3,322.48%-23.75M-335.44%-13.02M--------0.07%-7.23M86.05%-694K--5.53M-----------7.23M
Cash from discontinued investing activities
Investing cash flow -3,874.54%-28.26M-761.06%-36.43M73.32%9.52M231.55%5.9M-0.17%-7.25M96.48%-711K136.14%5.51M21,030.77%5.49M---4.48M-44.68%-7.23M
Financing cash flow
Cash flow from continuing financing activities -109.23%-11.13M-100.86%-1.07M-192.47%-4M5.24%-1.1M-262.28%-4.96M2,809.35%120.59M9,517.10%124.49M-8.57%-1.37M-2.73%-1.17M-86.12%-1.37M
Net issuance payments of debt -105.31%-6.9M--0---3.29M--0---3.62M--130M--130M--0--0--0
Net common stock issuance ---13K--0--0--0---13K--0--0--0--0--0
Cash dividends paid 0.00%-5.47M0.00%-1.37M0.00%-1.37M0.00%-1.37M0.00%-1.37M0.00%-5.47M0.00%-1.37M0.00%-1.37M0.00%-1.37M0.00%-1.37M
Proceeds from stock option exercised by employees 1,018.88%5.21M321.32%1.09M--1.77M90.87%397K--1.96M-80.74%466K460.87%258K--0-30.43%208K--0
Net other financing activities 10.16%-3.95M82.14%-785K---1.12M---133K---1.92M-214.81%-4.4M---4.4M--0--------
Cash from discontinued financing activities
Financing cash flow -109.23%-11.13M-100.86%-1.07M-192.47%-4M5.24%-1.1M-262.28%-4.96M2,809.35%120.59M9,517.10%124.49M-8.57%-1.37M-2.73%-1.17M-86.12%-1.37M
Net cash flow
Beginning cash position 175.91%159.55M338.62%146.82M376.77%149.92M221.45%142.4M175.91%159.55M-39.37%57.83M-57.24%33.47M-62.20%31.45M-50.02%44.3M-39.37%57.83M
Current changes in cash -152.23%-53.13M-132.04%-40.4M-253.13%-3.1M158.49%7.52M-26.79%-17.15M370.90%101.72M716.25%126.08M141.39%2.03M-135.83%-12.86M-100.56%-13.53M
End cash Position -33.30%106.42M-33.30%106.42M338.62%146.82M376.77%149.92M221.45%142.4M175.91%159.55M175.91%159.55M-57.24%33.47M-62.20%31.45M-50.02%44.3M
Free cash flow 24.25%-13.77M26.32%-2.91M-310.91%-8.63M137.83%2.73M-0.81%-4.96M35.38%-18.18M79.39%-3.94M42.70%-2.1M-66.97%-7.21M-388.01%-4.92M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Symbol Mini Chart % Chg
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
+14.85%
New Fortress Energy
NFE
+7.92%
Cars.com
CARS
+2.11%
Halozyme Therapeutics
HALO
+1.31%
Collegium Pharmaceutical
COLL
+0.40%

Unlock the Full List